Pharmacovigilance & Post-Marketing Safety

Long-term safety monitoring is essential for the success of biologics and biosimilars after market entry. This session will explore advanced pharmacovigilance strategies, risk management plans, and post-marketing surveillance systems that ensure ongoing safety and effectiveness. Topics include adverse event reporting, safety signal detection, real-world data integration, and the use of AI in safety monitoring. Attendees will learn how to design and implement robust risk mitigation frameworks that comply with global regulatory requirements. Comparative safety evaluations between originator biologics and biosimilars, including immunogenicity monitoring, will be highlighted. Emphasis will be placed on patient-centric pharmacovigilance models and how stakeholder education improves post-marketing outcomes. This session is tailored for safety officers, regulatory professionals, clinicians, and biopharma teams who are responsible for ensuring the safe and effective use of biologic therapies throughout their lifecycle.

    Related Conference of Pharmacovigilance & Post-Marketing Safety

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Pharmacovigilance & Post-Marketing Safety Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in